These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3182412)

  • 21. High-dose cisplatin with sodium thiosulfate protection.
    Pfeifle CE; Howell SB; Felthouse RD; Woliver TB; Andrews PA; Markman M; Murphy MP
    J Clin Oncol; 1985 Feb; 3(2):237-44. PubMed ID: 4038510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
    Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
    Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ototoxic effect of cisplatin on guinea pigs in relation to dosage.
    Laurell G; Engström B
    Hear Res; 1989 Mar; 38(1-2):27-33. PubMed ID: 2708157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined effect of cisplatin and furosemide on hearing function in guinea pigs.
    Laurell G; Engström B
    Hear Res; 1989 Mar; 38(1-2):19-26. PubMed ID: 2708156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. End points for cisplatin ototoxicity.
    Qureshy K; Blakley B; Alsaleh S; Quddusi T; Berard S
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S45-8. PubMed ID: 21453661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ototoxic effect and its prevention in administration of cisplatin].
    Bogomil'skiĭ MR; D'iakonova IN; Poliakov VG; Rakhmanova IV; Stakhovskaia OA; Tikhomirov AM
    Vestn Otorinolaringol; 2002; (2):7-10. PubMed ID: 12056168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs.
    Teranishi MA; Nakashima T
    Int J Pediatr Otorhinolaryngol; 2003 Feb; 67(2):133-9. PubMed ID: 12623149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ototoxicity of the anticancer drug cisplatin. An experimental study.
    Nakai Y; Konishi K; Chang KC; Ohashi K; Morisaki N; Minowa Y; Morimoto A
    Acta Otolaryngol; 1982; 93(1-6):227-32. PubMed ID: 7199807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
    Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J
    Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of geranylgeranylacetone against cisplatin-induced ototoxicity by auditory brainstem response, heat shock proteins and oxidative levels in guinea pigs.
    Lo WC; Wu CT; Lee HC; Young YH; Chang YL; Cheng PW
    Neurotoxicol Teratol; 2017 May; 61():29-35. PubMed ID: 28344103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ototoxic effect of topical ciclopirox as an antimycotic preparation.
    Baylancicek S; Serin GM; Ciprut A; Sari M; Akdaş F; Tutkun A
    Otol Neurotol; 2008 Oct; 29(7):910-3. PubMed ID: 18698269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
    Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
    Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
    J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of cisplatin-induced toxicity by selected dithiocarbamates.
    Walker EM; Fazekas-May MA; Heard KW; Yee S; Montague D; Jones MM
    Ann Clin Lab Sci; 1994; 24(2):121-33. PubMed ID: 8203821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.
    Wang J; Lloyd Faulconbridge RV; Fetoni A; Guitton MJ; Pujol R; Puel JL
    Neuropharmacology; 2003 Sep; 45(3):380-93. PubMed ID: 12871655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
    Church MW; Blakley BW; Burgio DL; Gupta AK
    J Assoc Res Otolaryngol; 2004 Sep; 5(3):227-37. PubMed ID: 15185124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs.
    Baba M; Matsumoto Y; Kashio A; Cabral H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2012 Jan; 157(1):112-7. PubMed ID: 21807044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.